Anticancer research
-
Anticancer research · Apr 2012
Adjuvant intravesical instillation for primary T1G3 bladder cancer: BCG versus MMC in Korea.
To compare the efficacy of bacillus Calmette-Guerin (BCG) and mitomycin-C (MMC) intravesical instillation for primary T1G3 bladder cancer (BC). ⋯ There were no statistically significant differences regarding recurrence and disease progression rate at the time of recurrence between the two adjuvant treatments in primary T1G3 BC. Thus, large prospective studies in Asian population are required.